Encéphalite limbique : une nouvelle manifestation auto-immune paranéoplasique associée au mélanome métastatique ?
- 20 February 2013
- journal article
- case report
- Published by Elsevier BV in Annales de Dermatologie et de Vénéréologie
- Vol. 140 (4), 278-281
- https://doi.org/10.1016/j.annder.2013.01.424
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Melanoma as a model tumour for immuno-oncologyAnnals Of Oncology, 2012
- Metastatic melanoma: spontaneous occurrence of auto antibodies is a good prognosis factor in a prospective cohortJournal of the European Academy of Dermatology and Venereology, 2011
- New concepts in paraneoplastic neurological syndromesRevue Neurologique, 2011
- Autoimmunity and treatment outcome in melanomaCurrent Opinion in Oncology, 2011
- Phase III Trial Comparing Adjuvant Treatment With Pegylated Interferon Alfa-2b Versus Observation: Prognostic Significance of Autoantibodies—EORTC 18991Journal of Clinical Oncology, 2010
- Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort studyAnnals Of Oncology, 2009
- Does spontaneous autoimmunity improve survival in visceral metastatic melanoma?British Journal of Dermatology, 2007
- Prognostic Significance of Autoimmunity during Treatment of Melanoma with InterferonNew England Journal of Medicine, 2006
- Neurological toxicity during metastatic melanoma treatment with fotemustineMelanoma Research, 2005
- Severe neurological disabilities after complete remission of advanced malignant melanoma following fotemustine therapy in combination with total brain irradiationMelanoma Research, 2002